B-School innovation professor discovers pathway between diabetes and Alzheimer's disease

by IOS PressIn a new paper published byThe Journal of Alzheimer's Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a

Updated on: February 28,2024 13

B-School innovation professor discovers pathway between diabetes and Alzheimer's disease

by IOS PressIn a new paper published byThe Journal of Alzheimer's Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a

Updated on:February 28,2024 13

How does the brain know whether our actions actually make a difference?

by Champalimaud Centre for the UnknownIn "controllable houses", the door's color determines which room it leads to. In contrast, in "uncontrollable houses" the sequence of room

Updated on: February 21,2024 7

How does the brain know whether our actions actually make a difference?

by Champalimaud Centre for the UnknownIn "controllable houses", the door's color determines which room it leads to. In contrast, in "uncontrollable houses" the sequence of room

Updated on:February 21,2024 7

Alzheimer's genetics point to new research direction

by Robyn Mills,University of AdelaideDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A University of Adelaide analysis of genetic mutations which c

Updated on: April 16,2024 14

Alzheimer's genetics point to new research direction

by Robyn Mills,University of AdelaideDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A University of Adelaide analysis of genetic mutations which c

Updated on:April 16,2024 14

An implant to prevent Alzheimer's

by Ecole Polytechnique Federale de LausanneAn infographic of how the implanted capsule releases antibodies to the brain. Credit: Patrick Aebischer (EPFL)In a cutting-edge treatment for Alzheimer&

Updated on: February 28,2024 14

An implant to prevent Alzheimer's

by Ecole Polytechnique Federale de LausanneAn infographic of how the implanted capsule releases antibodies to the brain. Credit: Patrick Aebischer (EPFL)In a cutting-edge treatment for Alzheimer&

Updated on:February 28,2024 14

Study shows that 'transcendent' thinking may grow teens' brains over time

byUniversity of Southern CaliforniaDepiction of coronal, sagittal, and axial views of the group-level default mode network (DMN; top) and left executive control network (left ECN; bottom) maps,

Updated on: March 28,2024 0

Study shows that 'transcendent' thinking may grow teens' brains over time

byUniversity of Southern CaliforniaDepiction of coronal, sagittal, and axial views of the group-level default mode network (DMN; top) and left executive control network (left ECN; bottom) maps,

Updated on:March 28,2024 0

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024 0

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024 0

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on: March 13,2024 12

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on:March 13,2024 12

Study reports on contributions to white matter injury in Alzheimer's disease

by Impact Journals LLCA vicious cycle generating WM injury driven by mixed vascular and ADNC in the aging human white matter. Diagnostic challenges for IHC and neuroimaging. Credit:Aging(2

Updated on: March 02,2024 19

Study reports on contributions to white matter injury in Alzheimer's disease

by Impact Journals LLCA vicious cycle generating WM injury driven by mixed vascular and ADNC in the aging human white matter. Diagnostic challenges for IHC and neuroimaging. Credit:Aging(2

Updated on:March 02,2024 19

Study shows activity of claustrum neurons controls alertness level, engagement of sensory information

byHebrew University of JerusalemApproach for hM3Dq DREADD experiments (left) and setup (right). Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48829-6A new study has unc

Updated on: July 08,2024 0

Study shows activity of claustrum neurons controls alertness level, engagement of sensory information

byHebrew University of JerusalemApproach for hM3Dq DREADD experiments (left) and setup (right). Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48829-6A new study has unc

Updated on:July 08,2024 0

Estrogen may offer protection against delirium

by Cedars-Sinai Medical CenterOophorectomy (OVX) and urinary tract infection (UTI)-mediated changes in cleaved caspase-3 (CC3). (A) A schematic of design of a preliminary experiment examining the

Updated on: February 05,2024 15

Estrogen may offer protection against delirium

by Cedars-Sinai Medical CenterOophorectomy (OVX) and urinary tract infection (UTI)-mediated changes in cleaved caspase-3 (CC3). (A) A schematic of design of a preliminary experiment examining the

Updated on:February 05,2024 15

Race of people given Alzheimer's blood tests may affect interpretation of results

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainThree experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently

Updated on: June 24,2024 7

Race of people given Alzheimer's blood tests may affect interpretation of results

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainThree experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently

Updated on:June 24,2024 7

Tau-based biomarker tracks Alzheimer's progression

by Washington University School of MedicineKanta Horie, PhD, works with a mass spectrometer that he uses to measure protein levels in cerebrospinal fluid samples. Horie and colleagues at Washingt

Updated on: June 18,2024 7

Tau-based biomarker tracks Alzheimer's progression

by Washington University School of MedicineKanta Horie, PhD, works with a mass spectrometer that he uses to measure protein levels in cerebrospinal fluid samples. Horie and colleagues at Washingt

Updated on:June 18,2024 7